BR9406747A - Uso de um composto compostos processos de preparação dos mesmos de inibição da ação de enzimas e de tratamento ou profilaxia de doença cardiovascular e formulação farmacêutica - Google Patents
Uso de um composto compostos processos de preparação dos mesmos de inibição da ação de enzimas e de tratamento ou profilaxia de doença cardiovascular e formulação farmacêuticaInfo
- Publication number
- BR9406747A BR9406747A BR9406747A BR9406747A BR9406747A BR 9406747 A BR9406747 A BR 9406747A BR 9406747 A BR9406747 A BR 9406747A BR 9406747 A BR9406747 A BR 9406747A BR 9406747 A BR9406747 A BR 9406747A
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- prophylaxis
- enzymes
- inhibiting
- action
- Prior art date
Links
- 208000024172 Cardiovascular disease Diseases 0.000 title 1
- 102000004190 Enzymes Human genes 0.000 title 1
- 108090000790 Enzymes Proteins 0.000 title 1
- -1 compound compound Chemical class 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 238000011321 prophylaxis Methods 0.000 title 1
- 238000011282 treatment Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
- C07C39/15—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings with all hydroxy groups on non-condensed rings, e.g. phenylphenol
- C07C39/16—Bis-(hydroxyphenyl) alkanes; Tris-(hydroxyphenyl)alkanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
- A61K31/37—Coumarins, e.g. psoralen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
- C07C39/14—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings with at least one hydroxy group on a condensed ring system containing two rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
- C07C39/15—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings with all hydroxy groups on non-condensed rings, e.g. phenylphenol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
- C07D311/16—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPL918193 | 1993-06-03 | ||
| PCT/AU1994/000297 WO1994028886A1 (en) | 1993-06-03 | 1994-06-03 | Use of natural products and related synthetic compounds for the treatment of cardiovascular disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9406747A true BR9406747A (pt) | 1996-04-02 |
Family
ID=3776946
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9406747A BR9406747A (pt) | 1993-06-03 | 1994-06-03 | Uso de um composto compostos processos de preparação dos mesmos de inibição da ação de enzimas e de tratamento ou profilaxia de doença cardiovascular e formulação farmacêutica |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US5741821A (pt) |
| EP (1) | EP0703780A4 (pt) |
| JP (1) | JPH09502163A (pt) |
| KR (1) | KR960702749A (pt) |
| CN (1) | CN1124922A (pt) |
| BG (1) | BG100166A (pt) |
| BR (1) | BR9406747A (pt) |
| CA (1) | CA2164317A1 (pt) |
| CZ (1) | CZ318795A3 (pt) |
| FI (1) | FI955786A (pt) |
| HU (1) | HUT74174A (pt) |
| NO (1) | NO954479L (pt) |
| PL (1) | PL311810A1 (pt) |
| SI (1) | SI9420037A (pt) |
| SK (1) | SK147995A3 (pt) |
| WO (1) | WO1994028886A1 (pt) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6504014B1 (en) | 1997-05-19 | 2003-01-07 | The John Hopkins University | Tissue specific prodrug |
| US6545131B1 (en) | 1997-05-19 | 2003-04-08 | The Johns Hopkins University | Tissue specific prodrug |
| WO1998052966A1 (en) | 1997-05-19 | 1998-11-26 | The Johns Hopkins University School Of Medecine | Tissue specific prodrug |
| US6538022B1 (en) * | 1997-09-24 | 2003-03-25 | Orion Corporation | Compounds for deactivating phospholamban function on Ca-ATPase (phopholamban inhibitors) |
| RU2137472C1 (ru) | 1998-10-12 | 1999-09-20 | Тихоокеанский институт биоорганической химии Дальневосточного отделения РАН | Лекарственный препарат "гистохром" для лечения острого инфаркта миокарда и ишемической болезни сердца |
| US6566560B2 (en) | 1999-03-22 | 2003-05-20 | Immugen Pharmaceuticals, Inc. | Resorcinolic compounds |
| GB2349217B (en) * | 1999-04-15 | 2001-04-04 | Devgen Nv | Compound screening methods |
| US7053042B1 (en) | 1999-07-29 | 2006-05-30 | Samuel Denmeade | Activation of peptide prodrugs by hK2 |
| US6541510B2 (en) * | 2000-09-28 | 2003-04-01 | Immugen Pharmaceuticals, Inc. | Antiviral methods and compounds |
| US20020137802A1 (en) * | 2000-09-28 | 2002-09-26 | Travis Craig R. | Methods and compounds for inhibiting eicosanoid metabolism and platelet aggregation |
| EP1206934A1 (en) * | 2000-11-15 | 2002-05-22 | B. Braun Melsungen Ag | Blockade of sodium channels by phenol derivatives |
| KR100704299B1 (ko) * | 2005-11-17 | 2007-04-09 | 한국생명공학연구원 | 신규한 퀴놀린계 화합물, 및 지네 추출물 또는 이로부터 분리된 화합물을 포함하는 심장순환계 질환의 예방 및 치료용 조성물 |
| US9024273B2 (en) * | 2010-04-20 | 2015-05-05 | Varian Semiconductor Equipment Associates, Inc. | Method to generate molecular ions from ions with a smaller atomic mass |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2321620A (en) * | 1940-10-10 | 1943-06-15 | Du Pont | Phenolic compounds |
| DE3527862A1 (de) * | 1985-08-02 | 1987-02-05 | Bayer Ag | Verfahren zur herstellung von bis-hydroxyphenyl-n-alkanen, neue bis-hydroxyphenyl-n-alkane und neue alkandione |
-
1994
- 1994-06-03 SK SK1479-95A patent/SK147995A3/sk unknown
- 1994-06-03 CA CA002164317A patent/CA2164317A1/en not_active Abandoned
- 1994-06-03 SI SI9420037A patent/SI9420037A/sl unknown
- 1994-06-03 WO PCT/AU1994/000297 patent/WO1994028886A1/en not_active Application Discontinuation
- 1994-06-03 CZ CZ953187A patent/CZ318795A3/cs unknown
- 1994-06-03 PL PL94311810A patent/PL311810A1/xx unknown
- 1994-06-03 BR BR9406747A patent/BR9406747A/pt not_active Application Discontinuation
- 1994-06-03 JP JP7501103A patent/JPH09502163A/ja active Pending
- 1994-06-03 EP EP94916850A patent/EP0703780A4/en not_active Withdrawn
- 1994-06-03 US US08/553,714 patent/US5741821A/en not_active Expired - Fee Related
- 1994-06-03 HU HU9503441A patent/HUT74174A/hu unknown
- 1994-06-03 CN CN94192317A patent/CN1124922A/zh active Pending
-
1995
- 1995-11-08 NO NO954479A patent/NO954479L/no unknown
- 1995-11-24 BG BG100166A patent/BG100166A/xx unknown
- 1995-12-01 FI FI955786A patent/FI955786A/fi unknown
- 1995-12-02 KR KR1019950705432A patent/KR960702749A/ko not_active Application Discontinuation
-
1997
- 1997-11-12 US US08/969,145 patent/US5859067A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| HU9503441D0 (en) | 1996-01-29 |
| FI955786A0 (fi) | 1995-12-01 |
| SI9420037A (en) | 1996-08-31 |
| JPH09502163A (ja) | 1997-03-04 |
| NO954479L (no) | 1996-02-02 |
| WO1994028886A1 (en) | 1994-12-22 |
| EP0703780A4 (en) | 1998-01-07 |
| US5741821A (en) | 1998-04-21 |
| KR960702749A (ko) | 1996-05-23 |
| FI955786A (fi) | 1996-01-29 |
| CA2164317A1 (en) | 1994-12-22 |
| BG100166A (en) | 1996-11-29 |
| SK147995A3 (en) | 1997-04-09 |
| PL311810A1 (en) | 1996-03-18 |
| NO954479D0 (no) | 1995-11-08 |
| EP0703780A1 (en) | 1996-04-03 |
| CN1124922A (zh) | 1996-06-19 |
| US5859067A (en) | 1999-01-12 |
| HUT74174A (en) | 1996-11-28 |
| CZ318795A3 (en) | 1996-06-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9406128A (pt) | Uso de um composto processo para o tratamento e/ou prevençao de distúrbios psicóticos composto composiçao farmacêutica processos para a preparaçao de um composto e de uma composiçao farmacêutica | |
| ATE265857T1 (de) | Pharmazeutische oder diätetische zusammensetzung zur prävention oder behandlung von hyperoxalurie | |
| BR1100329A (pt) | Composto e formulação farmacêutica | |
| BR9604632A (pt) | Compostos bicíclicos aromáticos utilizaçao de pelo menos um dos compostos composiçao farmacêutica composiçao cosmética e utilizaçao de uma composiçao cosmética | |
| KR950703566A (ko) | 티에노디아제핀 화합물 및 그의 의약 용도[thienodiazepine compound and medicinal use thereof] | |
| BR9709915A (pt) | Composto composição farmacêutica utilização do composto e processos para o tratamento ou a prevençao de distúrbios fisiológicos asociados com um excesso de taquiquininas e para preparação do composto | |
| BR9407799A (pt) | Composição de matéria método de tratamento e composição farmaceutica | |
| BR9408148A (pt) | Processo para tratamento de arritmia composto e formulação farmacêutica | |
| MX9202839A (es) | 4-aminoquinolinas y composiciones farmaceuticas de las mismas. | |
| IT1227899B (it) | Rivestimento totale o parziale di principi attivi farmaceutici e relative composizioni | |
| NO981008L (no) | Farmas÷ytisk formulering | |
| BR9406747A (pt) | Uso de um composto compostos processos de preparação dos mesmos de inibição da ação de enzimas e de tratamento ou profilaxia de doença cardiovascular e formulação farmacêutica | |
| NO305903B1 (no) | Benzonitriler og benzofluorider, legemidler bestående av forbindelsene, farmasöytiske preparater inneholdende forbindelsene, samt anvendelse av forbindelsene for fremstilling av farmasöytiske preparater | |
| FI963883A (fi) | Farmaseuttisia valmisteita ja lääkeaineita endoteelin toimintahäiriön ehkäisemiseksi ja hoitamiseksi | |
| BR9610733A (pt) | Composto processos para a preparação do mesmo e para o tratamento de um mamífero composição farmacêutica e utilização de um composto | |
| DE4495520T1 (de) | Verfahren und pharmazeutische Zusammensetzung zum zielgerichten Anwenden von Wirkstoffen | |
| NO307930B1 (no) | Benzo[f]kinolinoner, farmasøytisk formulering omfattende samme og anvendelse av samme for fremstilling av formulering for behandling | |
| CA2025855A1 (en) | Pharmaceutical Compositions Having Activity on the Cutaneous Microcirculation | |
| BR9706938A (pt) | Composto uso do mesmo formulação farmacêutica e processos para produzir o composto e para o tratamento ou a prevenção de sintomas ou efeitos de uma infecção virótica em um mamífero infectado incluindo um humano | |
| NO934832D0 (no) | Farmasoeytisk sammensetning for forhindring eller behandling av ar terioscherose | |
| BR9509925A (pt) | Composição e uso da composição para prevenção ou tratamento de infecção por hiv-1 | |
| NO960529L (no) | Substituerte benzensulfonylureaer og -tioureaer, fremgangsmåte for fremstilling av disse, og deres anvendelse for fremstilling av farmasöytiske preparater samt farmasöytiske preparater inneholdende forbindelsene | |
| BR9610851A (pt) | Composto processo de preparação de composto medicamento composição farmacêuticas e utilização do composto | |
| AU6527390A (en) | Pharmaceutical compositions for the treatment of ataxy and equilibrium problems | |
| NO973341D0 (no) | Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for vasodilatorisk behandling eller profylakse |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EG | Technical examination (opinion): publication of technical examination (opinion) | ||
| FC | Decision: refusal |